Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+231.3%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+231.3%/yr
vs +22.2%/yr prior
Acceleration
+209.1pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
36.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202574.50+1454.2%
2024-5.50-248.4%
20233.71+81.0%
20222.05+785.7%
20210.23+143.6%
2020-0.53+79.5%
2019-2.58-381.3%
20180.92+5868.7%
20130.02-27.0%
20120.02-